Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316021978> ?p ?o ?g. }
- W2316021978 endingPage "332" @default.
- W2316021978 startingPage "323" @default.
- W2316021978 abstract "Irreversible inhibition of Bruton’s tyrosine kinase (BTK) by ibrutinib represents an important therapeutic advance for the treatment of chronic lymphocytic leukemia (CLL). However, ibrutinib also irreversibly inhibits alternative kinase targets, which potentially compromises its therapeutic index. Acalabrutinib (ACP-196) is a more selective, irreversible BTK inhibitor that is specifically designed to improve on the safety and efficacy of first-generation BTK inhibitors." @default.
- W2316021978 created "2016-06-24" @default.
- W2316021978 creator A5000921376 @default.
- W2316021978 creator A5001388908 @default.
- W2316021978 creator A5006104041 @default.
- W2316021978 creator A5011011110 @default.
- W2316021978 creator A5013974745 @default.
- W2316021978 creator A5014241029 @default.
- W2316021978 creator A5016570475 @default.
- W2316021978 creator A5021564306 @default.
- W2316021978 creator A5028451729 @default.
- W2316021978 creator A5029736763 @default.
- W2316021978 creator A5030359399 @default.
- W2316021978 creator A5031412066 @default.
- W2316021978 creator A5036657478 @default.
- W2316021978 creator A5040412322 @default.
- W2316021978 creator A5047631289 @default.
- W2316021978 creator A5048473316 @default.
- W2316021978 creator A5050861419 @default.
- W2316021978 creator A5051654875 @default.
- W2316021978 creator A5052543382 @default.
- W2316021978 creator A5053545098 @default.
- W2316021978 creator A5059854479 @default.
- W2316021978 creator A5067807887 @default.
- W2316021978 creator A5073366739 @default.
- W2316021978 creator A5074839524 @default.
- W2316021978 creator A5075229974 @default.
- W2316021978 creator A5083822738 @default.
- W2316021978 creator A5087432759 @default.
- W2316021978 creator A5089428686 @default.
- W2316021978 creator A5090247275 @default.
- W2316021978 creator A5090615083 @default.
- W2316021978 date "2016-01-28" @default.
- W2316021978 modified "2023-10-17" @default.
- W2316021978 title "Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia" @default.
- W2316021978 cites W1020989877 @default.
- W2316021978 cites W1601587199 @default.
- W2316021978 cites W1935657689 @default.
- W2316021978 cites W1972593274 @default.
- W2316021978 cites W1976225087 @default.
- W2316021978 cites W1986579976 @default.
- W2316021978 cites W1999128869 @default.
- W2316021978 cites W2011950935 @default.
- W2316021978 cites W2018466312 @default.
- W2316021978 cites W2019655196 @default.
- W2316021978 cites W2024216962 @default.
- W2316021978 cites W2033867789 @default.
- W2316021978 cites W2054526083 @default.
- W2316021978 cites W2065338378 @default.
- W2316021978 cites W2067064694 @default.
- W2316021978 cites W2071549499 @default.
- W2316021978 cites W2075875145 @default.
- W2316021978 cites W2085691086 @default.
- W2316021978 cites W2089103836 @default.
- W2316021978 cites W2095447519 @default.
- W2316021978 cites W2108206643 @default.
- W2316021978 cites W2120319857 @default.
- W2316021978 cites W2140395974 @default.
- W2316021978 cites W2140606816 @default.
- W2316021978 cites W2142099365 @default.
- W2316021978 cites W2144648936 @default.
- W2316021978 cites W2154066874 @default.
- W2316021978 cites W2163690533 @default.
- W2316021978 cites W2312332840 @default.
- W2316021978 cites W2340425144 @default.
- W2316021978 cites W2346748817 @default.
- W2316021978 cites W4293241248 @default.
- W2316021978 cites W4210733855 @default.
- W2316021978 doi "https://doi.org/10.1056/nejmoa1509981" @default.
- W2316021978 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4862586" @default.
- W2316021978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26641137" @default.
- W2316021978 hasPublicationYear "2016" @default.
- W2316021978 type Work @default.
- W2316021978 sameAs 2316021978 @default.
- W2316021978 citedByCount "732" @default.
- W2316021978 countsByYear W23160219782015 @default.
- W2316021978 countsByYear W23160219782016 @default.
- W2316021978 countsByYear W23160219782017 @default.
- W2316021978 countsByYear W23160219782018 @default.
- W2316021978 countsByYear W23160219782019 @default.
- W2316021978 countsByYear W23160219782020 @default.
- W2316021978 countsByYear W23160219782021 @default.
- W2316021978 countsByYear W23160219782022 @default.
- W2316021978 countsByYear W23160219782023 @default.
- W2316021978 crossrefType "journal-article" @default.
- W2316021978 hasAuthorship W2316021978A5000921376 @default.
- W2316021978 hasAuthorship W2316021978A5001388908 @default.
- W2316021978 hasAuthorship W2316021978A5006104041 @default.
- W2316021978 hasAuthorship W2316021978A5011011110 @default.
- W2316021978 hasAuthorship W2316021978A5013974745 @default.
- W2316021978 hasAuthorship W2316021978A5014241029 @default.
- W2316021978 hasAuthorship W2316021978A5016570475 @default.
- W2316021978 hasAuthorship W2316021978A5021564306 @default.
- W2316021978 hasAuthorship W2316021978A5028451729 @default.
- W2316021978 hasAuthorship W2316021978A5029736763 @default.
- W2316021978 hasAuthorship W2316021978A5030359399 @default.
- W2316021978 hasAuthorship W2316021978A5031412066 @default.
- W2316021978 hasAuthorship W2316021978A5036657478 @default.